Abeona Therapeutics Inc
ABEO
$5.25+1.74%
End of day · as of Oct 1, 2026, 9:16 AM ET
Mkt cap
$301.82M
EV/Sales
41.8
P/E ratio
N/A
FY2025 Revenue
$5.82M
EPS (TTM)
$-1.12
Gross Margin (FY2025)
73.68%
Profit Margin (FY2025)
1223.08%
Beta
1.55
Div yield
N/A
Sector
Healthcare
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Latest reported ABEO revenue for 2025-12-31 was $5.8M. Net income was $71.2M. Revenue was up 37.1% from 2024-12-31 to 2025-12-31. ABEO currently screens at market cap $301.8M.
Use this ABEO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ABEO income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Abeona Therapeutics Inc (ABEO) is a biotechnology company in the Healthcare sector.
Latest cached Abeona Therapeutics Inc (ABEO) revenue for Dec 31, 2025 was $5.8M. Net income was $71.2M. Statements: https://lician.com/financials/abeo
Abeona Therapeutics Inc (ABEO) market capitalization is $301.8M on the latest cached snapshot.
Abeona Therapeutics Inc (ABEO) cached previous close $5.16; day range $5.10 – $5.33; volume 1,130,668. Session quote: https://lician.com/quote/abeo
Abeona Therapeutics Inc (ABEO) latest cached earnings event is "ABEO earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ABEO filing is 8-K · Sep 15, 2026. Filings: https://lician.com/sec/abeo